These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7413497)

  • 21. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.
    Leandro MJ; Cambridge G; Edwards JC; Ehrenstein MR; Isenberg DA
    Rheumatology (Oxford); 2005 Dec; 44(12):1542-5. PubMed ID: 16188950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and immunologic course of systemic lupus erythematosus in a 12-year-old girl].
    Górska A; Urban M; Minkiewicz L
    Przegl Lek; 1995; 52(9):474-6. PubMed ID: 8834650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intravenous administration of immunoglobulins in systemic lupus erythematosus: review of the literature and initial clinical experiences].
    Pirner K; Rubbert A; Burmester GR; Kalden JR; Manger B
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():131-5; discussion 136. PubMed ID: 8499742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pregnancy and systemic lupus erythematosus].
    Moga Sampere I; Formiga Pérez F; Canet González R; Pac Ferraz M; Mitjavila Villero F; Fernández-Nogués F
    Med Clin (Barc); 1993 Oct; 101(14):530-3. PubMed ID: 8231397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-DNA antibodies: structure and pathogenic role].
    Ayed K
    Arch Inst Pasteur Tunis; 2000; 77(1-4):3-9. PubMed ID: 14658221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporine therapy for acquired factor VIII inhibitor in a patient with systemic lupus erythematosus.
    Schulman S; Langevitz P; Livneh A; Mortinowitz U; Seligsohn U; Varon D
    Thromb Haemost; 1996 Sep; 76(3):344-6. PubMed ID: 8883268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced lupus erythematosus.
    Vedove CD; Del Giglio M; Schena D; Girolomoni G
    Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The characteristics of systemic lupus erythematosus. A study in a general hospital.
    Karadsheh MF; Nimri FA; Ajlouni YM; Dneibat WA; Karadsheh RF
    Saudi Med J; 2000 Mar; 21(3):282-6. PubMed ID: 11533799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ischemic colitis following colonoscopy in a systemic lupus erythematosus patient: report of a case.
    Versaci A; Macrì A; Scuderi G; Bartolone S; Familiari L; Lupattelli T; Famulari C
    Dis Colon Rectum; 2005 Apr; 48(4):866-9. PubMed ID: 15750796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rituximab therapy for childhood-onset systemic lupus erythematosus.
    Willems M; Haddad E; Niaudet P; Koné-Paut I; Bensman A; Cochat P; Deschênes G; Fakhouri F; Leblanc T; Llanas B; Loirat C; Pillet P; Ranchin B; Salomon R; Ulinski T; Bader-Meunier B;
    J Pediatr; 2006 May; 148(5):623-627. PubMed ID: 16737873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus.
    Ng KP; Manson JJ; Rahman A; Isenberg DA
    Arthritis Rheum; 2006 Dec; 55(6):900-4. PubMed ID: 17139667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-induced systemic lupus erythematosus after 7 years of treatment with carbamazepine.
    Pelizza L; De Luca P; La Pesa M; Minervino A
    Acta Biomed; 2006 Apr; 77(1):17-9. PubMed ID: 16856703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Idiotypic vaccination with a murine anti-dsDNA antibody: phase I study in patients with nonactive systemic lupus erythematosus with nephritis.
    Spertini F; Leimgruber A; Morel B; Khazaeli MB; Yamamoto K; Dayer JM; Weisbart RH; Lee ML
    J Rheumatol; 1999 Dec; 26(12):2602-8. PubMed ID: 10606369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocarditis as an initial manifestation of systemic lupus erythematosus.
    Routray SN; Mishra TK; Patnaik UK; Behera M
    J Assoc Physicians India; 2004 Aug; 52():673-4. PubMed ID: 15847368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic options for refractory massive pleural effusion in systemic lupus erythematosus: a case study and review of the literature.
    Breuer GS; Deeb M; Fisher D; Nesher G
    Semin Arthritis Rheum; 2005 Apr; 34(5):744-9. PubMed ID: 15846590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial childhood systemic lupus erythematosus: report of 2 cases.
    Roy AK; Pal D; Das S; Kar C; Maiti A
    J Indian Med Assoc; 2007 Mar; 105(3):141, 148. PubMed ID: 17824469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Soluble interleukin 2 receptor as activity parameter in serum of systemic and discoid lupus erythematosus].
    Blum C; Zillikens D; Tony HP; Hartmann AA; Burg G
    Hautarzt; 1993 May; 44(5):290-5. PubMed ID: 8320115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
    Vlachoyiannopoulos PG; Toya SP; Katsifis G; Zintzaras E; Tzioufas AG; Moutsopoulos HM
    J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.